| Issue |
Title |
File |
| Vol 80, No 2 (2025) |
Pharmaceutical Product Manufacturing Readiness Levels |
 (Rus)
|
|
Pyatigorsky A.M., Brkich G.E., Beregovykh V.V., Pyatigorskaya N.V., Zyryanov O.A., Kuznetsov A.O.
|
| Vol 80, No 1 (2025) |
Water soluble peroral pharmaceutical form of phosphatidylcholine: experimental and clinical data in combined hyperlipidemia |
 (Rus)
|
|
Markin S.S., Kuharchuk V.V., Lisitsa A.V., Ponomarenko E.A., Romashova Y.A., Pleshakova T.O., Ipatova O.M., Tikhonova E.G., Guseva M.K., Kutsenko V.A., Ivanov S.V., Yarovaya E.B., Zubareva M.Y., Beregovykh V.V., Archakov A.I.
|
| Vol 80, No 1 (2025) |
Evaluation of changes in the characteristics of beta2-adrenergic receptors in healthy volunteers under the influence of cholinergics using a modified radioligand analysis technique |
 (Rus)
|
|
Eremenko A.V., Smolyakova E.V., Skoblov Y.S., Rvacheva A.V., Zykov K.A.
|
| Vol 79, No 6 (2024) |
Antibiotic resistance is a Russia’s most important challenge: scientific and practical aspects, solutions |
 (Rus)
|
|
Starodubov V.I., Beregovykh V.V., Akimkin V.G., Kozlov R.S., Tutelyan A.V., Ugleva S.V., Stephani S., Rex J., Karaulov A.V., Sidorenko S.V., Basetti M., Priputnevich T.V., Stoma I.O., Svidzinsky A.V., Eckmann C., Tyumentsev A.I., Tyumentseva M.A., Prelovskaya A.N.
|
| Vol 79, No 6 (2024) |
Methodological foundations of pharmaceutical development of cell-based preparations |
 (Rus)
|
|
Lyundup A.V., Beregovykh V.V.
|
| Vol 79, No 4 (2024) |
Polypharmacotherapy: the Use of Artificial Intelligence to Reduce Risk of Adverse Drug Reactions (Review) |
 (Rus)
|
|
Beregovykh V.V., Panteleev V.I., Shimanovsky N.L.
|
| Vol 79, No 4 (2024) |
Phenotypic Mechanisms of Biofilm Resistance to Antibiotics |
 (Rus)
|
|
Savilov E.D., Markova Y.A., Belkova N.L.
|
| Vol 79, No 3 (2024) |
The Role of Artificial Intelligence in Reducing the Risk of Adverse Reactions in Multiple Drug Interactions |
 (Rus)
|
|
Shimanovsky N.L., Sudakov V.A., Beregovykh V.V.
|
| Vol 79, No 3 (2024) |
Pharmacological Regulation Possibilities of HIF for Its’ Mediated Pathologies in Clinical Practice |
 (Rus)
|
|
Novikov V.E., Levchenkova O.S.
|
| Vol 78, No 3 (2023) |
Comprehensive Assessment of Technological Readiness of an Innovative Project during the Development of a Pharmaceutical Product |
 (Rus)
|
|
Pyatigorsky A.M., Brkich G.E., Beregovykh V.V., Pyatigorskaya N.V.
|
| Vol 78, No 1 (2023) |
From Molecule to Drug. Pharmaceutical Logistics Approach |
 (Rus)
|
|
Petrov V.I., Tyurenkov I.N., Kurkin D.V.
|
| 1 - 11 of 11 Items |
|